aspirin has been researched along with busulfan in 35 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (22.86) | 18.7374 |
| 1990's | 7 (20.00) | 18.2507 |
| 2000's | 9 (25.71) | 29.6817 |
| 2010's | 10 (28.57) | 24.3611 |
| 2020's | 1 (2.86) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Medici, TC | 1 |
| Glusa, E; Hoffman, A; Markwardt, F; Nowak, G | 1 |
| Horna, E; Jeri, A; Rojas, M | 1 |
| Michiels, JJ; Roelandt, JR; Scheffer, MG; Simoons, ML | 1 |
| Niikura, H | 1 |
| Rosenow, EC | 1 |
| Braylan, RC; Elfenbein, GJ; Jones, J; Oblon, DJ; Weiner, RS | 1 |
| Giles, AR; Greenwood, P; Tinlin, S | 1 |
| Berliner, S; Pinkhas, J; Shaklai, M; Shoenfeld, Y | 1 |
| Lindemans, J; Michiels, JJ; van Genderen, PJ; van Vliet, HH | 1 |
| Griesshammer, M; Heimpel, H; Pearson, TC | 1 |
| Dapling, RB; Greaves, M; Nelson, ME; Snowden, JA; Talbot, JF; West, J | 1 |
| Kaaja, RJ; Leinonen, PJ | 1 |
| Michiels, JJ | 1 |
| Fabris, F; Girolami, A; Menapace, L; Randi, ML; Rossi, C | 1 |
| Fabris, F; Girolami, A; Randi, ML; Rossi, C | 1 |
| Tefferi, A; Wright, CA | 1 |
| Solberg, LA | 1 |
| Berneman, Z; Michiels, JJ; Schroyens, W; van Urk, H | 1 |
| Cirillo, MC; Giorgi, R; Gonçalves, LR; Nogueira, TO; Sano-Martins, IS; Santoro, ML; Senise, LV; Yamashita, KM | 1 |
| Tefferi, A | 1 |
| Barbui, T; Tefferi, A | 2 |
9 review(s) available for aspirin and busulfan
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Thrombosis in various diseases: myeloproliferative disorders].
Topics: Aspirin; beta-Thromboglobulin; Blood Coagulation Factors; Busulfan; Carbazilquinone; Dipyridamole; Humans; Myeloproliferative Disorders; Platelet Factor 3; Platelet Factor 4; Thrombosis | 1986 |
The spectrum of drug-induced pulmonary disease.
Topics: Adrenal Cortex Hormones; Aerosols; Analgesics; Aspirin; Autonomic Agents; Bleomycin; Busulfan; Contraceptives, Oral; Cyclophosphamide; Dextropropoxyphene; Drug Hypersensitivity; Heroin; Humans; Lung Diseases; Lupus Erythematosus, Systemic; Methadone; Methotrexate; Mineral Oil; Nitrofurantoin; Oxygen Inhalation Therapy; Paraquat; Pituitary Gland, Posterior; Pleural Effusion; Sulfonamides; Tissue Extracts | 1972 |
Erythromelalgic, thrombotic and hemorrhagic manifestations in 50 cases of thrombocythemia.
Topics: Adult; Aged; Aspirin; Busulfan; Double-Blind Method; Erythromelalgia; Female; Gangrene; Hemorrhage; Humans; Indomethacin; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Count; Polycythemia Vera; Splenomegaly; Thermography; Thrombocytosis; Thrombosis | 1996 |
Essential thrombocythemia and pregnancy.
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Aspirin; Busulfan; Combined Modality Therapy; Dipyridamole; Female; Fetal Death; Fetal Growth Retardation; Hemorrhage; Humans; Hydroxyurea; Infarction; Interferon-alpha; Placenta; Platelet Aggregation Inhibitors; Plateletpheresis; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Outcome; Thrombocythemia, Essential | 1996 |
A single institutional experience with 43 pregnancies in essential thrombocythemia.
Topics: Abortion, Induced; Abortion, Spontaneous; Abruptio Placentae; Adult; Anticoagulants; Aspirin; Busulfan; Erythromelalgia; Female; Fetal Death; Follow-Up Studies; Heparin; Humans; Hydroxyurea; Migraine Disorders; Obstetric Labor, Premature; Phosphorus Radioisotopes; Platelet Aggregation Inhibitors; Platelet Count; Plateletpheresis; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Outcome; Pregnancy Trimester, First; Pregnancy, Ectopic; Pregnancy, High-Risk; Quinazolines; Retrospective Studies; Risk; Thrombocythemia, Essential; Uterine Hemorrhage | 2001 |
Therapeutic options for essential thrombocythemia and polycythemia vera.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Aspirin; Busulfan; Fibrinolytic Agents; Humans; Hydroxyurea; Immunologic Factors; Immunosuppressive Agents; Interferon-alpha; Nucleic Acid Synthesis Inhibitors; Phosphorus Radioisotopes; Polycythemia Vera; Quinazolines; Risk Assessment; Thrombocytosis | 2002 |
Polycythemia vera and essential thrombocythemia: 2012 update on diagnosis, risk stratification, and management.
Topics: Acute Disease; Age Factors; Alkylating Agents; Anticoagulants; Aspirin; Busulfan; Disease Management; Disease Progression; DNA Mutational Analysis; Humans; Hydroxyurea; Interferon-alpha; Janus Kinase 2; Leukemia, Myeloid; Leukocyte Count; Phlebotomy; Polycythemia Vera; Randomized Controlled Trials as Topic; Risk Assessment; Survival Analysis; Thrombocythemia, Essential; Thrombophilia; Thrombosis | 2012 |
Polycythemia vera and essential thrombocythemia: 2021 update on diagnosis, risk-stratification and management.
Topics: Age Factors; Aspirin; Busulfan; Calreticulin; Disease-Free Survival; Humans; Interferon-alpha; Janus Kinase 2; Mutation; Polycythemia Vera; Receptors, Thrombopoietin; Risk Assessment; Risk Factors; Survival Rate; Thrombocythemia, Essential | 2020 |
2 trial(s) available for aspirin and busulfan
| Article | Year |
|---|---|
Normal life expectancy and thrombosis-free survival in aspirin treated essential thrombocythemia.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Aspirin; Busulfan; Coronary Disease; Disease-Free Survival; Erythromelalgia; Female; Follow-Up Studies; Hemorrhage; Humans; Ischemia; Life Expectancy; Logistic Models; Male; Middle Aged; Myeloproliferative Disorders; Platelet Count; Prospective Studies; Risk Factors; Survival Rate; Syndrome; Thrombocythemia, Essential; Thrombosis | 1999 |
Aspirin seems as effective as myelosuppressive agents in the prevention of rethrombosis in essential thrombocythemia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aspirin; Busulfan; Disease-Free Survival; Female; Hemorrhage; Humans; Hydroxyurea; Immunosuppressive Agents; Male; Middle Aged; Retrospective Studies; Survival Rate; Thrombocythemia, Essential; Thrombosis | 1999 |
24 other study(ies) available for aspirin and busulfan
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
[Drug-induced lung diseases].
Topics: Aspirin; Asthma; Bronchitis; Busulfan; Contraceptives, Oral, Hormonal; Dose-Response Relationship, Drug; Drug Hypersensitivity; Drug Interactions; Drug Tolerance; Heroin; Humans; Iodides; Lung Diseases; Methysergide; Pituitary Hormones, Posterior; Pleural Diseases; Polyarteritis Nodosa; Pulmonary Edema; Pulmonary Embolism; Pulmonary Eosinophilia; Trypsin | 1979 |
The influence of drugs on disseminated intravascular coagulation (dic). III. Effects of busulfan-induced thrombocytopenia and inhibition of platelet function by acetylsalicylic acid.
Topics: Animals; Aspirin; Busulfan; Disseminated Intravascular Coagulation; Fibrinogen; Male; Platelet Aggregation; Rats; Thrombin; Thrombocytopenia | 1979 |
[Essential thrombocytosis. Presentation of one case (author's transl)].
Topics: Adult; Aspirin; Busulfan; Humans; Male; Thrombocythemia, Essential | 1975 |
Thrombocythemia and coronary artery disease.
Topics: Adult; Aged; Aspirin; Busulfan; Coronary Disease; Female; Humans; Male; Middle Aged; Polycythemia Vera; Thrombocythemia, Essential; Thrombosis | 1991 |
The reversal of myelofibrosis associated with chronic myelogenous leukemia after allogeneic bone marrow transplantation.
Topics: Adult; Allopurinol; Aspirin; Bone Marrow; Bone Marrow Transplantation; Busulfan; Drug Therapy, Combination; Fibroblasts; Hematopoiesis; Humans; Leukemia, Myeloid; Male; Primary Myelofibrosis; Splenectomy | 1983 |
A platelet release defect induced by aspirin or penicillin G does not increase gastrointestinal blood loss in thrombocytopenic rabbits.
Topics: Animals; Aspirin; Blood Platelet Disorders; Busulfan; Gastrointestinal Hemorrhage; Male; Penicillin G; Platelet Aggregation; Rabbits; Thrombocytopenia | 1984 |
Conservative treatment of Budd-Chiari syndrome in polycythemia vera.
Topics: Aspirin; Budd-Chiari Syndrome; Busulfan; Dipyridamole; Female; Furosemide; Humans; Leukapheresis; Middle Aged; Polycythemia Vera | 1981 |
The microvasculature in myeloproliferative disease. A study using retinal fluorescein angiography.
Topics: Adult; Aged; Aged, 80 and over; Allergens; Antineoplastic Agents; Arterial Occlusive Diseases; Aspirin; Busulfan; Eye Abnormalities; Female; Fluorescein Angiography; Humans; Hydroxyurea; Immunosuppressive Agents; Male; Microcirculation; Middle Aged; Myeloproliferative Disorders; Myocardial Ischemia; Platelet Aggregation Inhibitors; Platelet Count; Polycythemia; Radionuclide Imaging; Retinal Hemorrhage; Retinal Vessels; Thrombocytosis; Visual Acuity | 1996 |
Successful pregnancies after recurrent abortions in mild essential thrombocythemia.
Topics: Abortion, Habitual; Adult; Aspirin; Busulfan; Female; Humans; Platelet Aggregation Inhibitors; Pregnancy; Pregnancy Complications, Hematologic; Remission Induction; Thrombocytosis | 1998 |
Essential thrombocythemia in young adults: major thrombotic complications and complications during pregnancy--a follow-up study in 68 patients.
Topics: Acute Disease; Adult; Age Factors; Arteriosclerosis; Aspirin; Busulfan; Cohort Studies; Disease-Free Survival; Female; Follow-Up Studies; Hemorrhage; Heparin; Humans; Hydroxyurea; Leukemia; Male; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Complications, Hematologic; Pregnancy Outcome; Primary Myelofibrosis; Prospective Studies; Risk Factors; Splenectomy; Thrombocythemia, Essential; Venous Thrombosis; Warfarin | 2000 |
Aspirin-responsive painful red, blue, black toe, or finger syndrome in polycythemia vera associated with thrombocythemia.
Topics: Aged; Aspirin; Busulfan; Erythromelalgia; Female; Fingers; Hematocrit; Humans; Male; Middle Aged; Platelet Count; Polycythemia Vera; Recurrence; Thrombocytosis; Toes | 2003 |
Involvement of circulating platelets on the hyperalgesic response evoked by carrageenan and Bothrops jararaca snake venom.
Topics: Animals; Aspirin; Blood Platelets; Bothrops; Busulfan; Carrageenan; Clopidogrel; Crotalid Venoms; Cyclooxygenase 1; Hyperalgesia; Male; Rats; Rats, Wistar; Thrombocytopenia; Ticlopidine | 2011 |
Polycythemia vera and essential thrombocythemia: 2019 update on diagnosis, risk-stratification and management.
Topics: Adult; Aspirin; Bone Marrow; Busulfan; Disease Management; Disease Progression; Hemorrhage; Humans; Hydroxyurea; Interferon-alpha; Janus Kinase 2; Mutation; Phlebotomy; Pipobroman; Polycythemia Vera; Primary Myelofibrosis; Randomized Controlled Trials as Topic; Risk Factors; Survival Analysis; Thrombocythemia, Essential; Thrombosis; Young Adult | 2019 |